Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
06/1998
06/24/1998EP0849263A2 Pharmaceutical substituted propanoic acid derivatives
06/24/1998EP0848696A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
06/24/1998CN1185786A Sugar-modified cytostatics
06/24/1998CN1185435A Sulfamide-substituted compound, preparation method, and medicinal preparation containing same
06/23/1998US5770743 1,2-Dioxetane compounds as chemiluminescent labels for organic and biological molecules
06/23/1998US5770383 Tricyclic retinoids, methods for their production and use
06/23/1998US5770382 Tricyclic retinoids, methods for their production and use
06/23/1998US5770378 Tricyclic retinoids, methods for their production and use
06/23/1998US5770115 Polyphenolic antioxidant, uv absorber, hindered amine light stabilizer, naphthopyran dye
06/18/1998WO1998025916A1 Novel benzopyran derivatives
06/18/1998WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
06/18/1998WO1998025629A1 Prophylactic and therapeutic agent for inflammatory intestinal diseases
06/18/1998WO1998025616A1 Leukotriene antagonists for cerebral focal stroke
06/18/1998WO1998025615A1 Leukotriene antagonists for oral squamous cell carcinoma
06/18/1998WO1998025606A1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
06/18/1998WO1998025588A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
06/18/1998DE19652522A1 Method of concentrating tocopherol(s) and/or sterol(s)
06/18/1998CA2274908A1 Leukotriene antagonists for cerebral focal stroke
06/18/1998CA2274855A1 Leukotriene antagonists for oral squamous cell carcinoma
06/18/1998CA2274839A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions
06/18/1998CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
06/17/1998EP0847999A1 N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them
06/17/1998EP0847996A1 Sulfonamide substituted compounds as K-channel blockers
06/17/1998CN1185153A Benzopyrans and pharmaceutical composition contg. same
06/17/1998CN1185113A Ginkgo biloba flavonoid extract which is terpene-free and/or has high flavonoid heteroside content
06/17/1998CA2224835A1 Pharmaceutical compounds
06/16/1998US5767292 Processes for preparing 1-methoxy-2-propyl 3-(7-diethylamino-2-oxo-2H-chromen-3-yl)-3-oxopropionate
06/16/1998US5767290 Preparation of protected amines or alkylated amino acids
06/16/1998US5767162 Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists
06/16/1998US5767132 Pyridyl chroman
06/16/1998US5767116 Bicyclic aromatic compounds as therapeutic agents
06/16/1998CA2224885A1 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them
06/16/1998CA2132831C Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
06/11/1998WO1998024791A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
06/11/1998WO1998024779A1 Process for crystallizing d-alpha-tocopheryl succinate
06/11/1998WO1998024529A1 Purification of vitamin e
06/11/1998CA2272330A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
06/10/1998EP0846694A1 Morphinan derivative and its pharmaceutical applications
06/10/1998EP0846027A1 Cloth or cloth-like packing which is subject to low pressure losses and has an ordered structure for use in material-exchange columns and rectification method using such packing
06/10/1998EP0827501A4 Non-nucleosidic coumarin derivatives as polynucleotide-cross-linking agents
06/10/1998CN1184422A Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
06/10/1998CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use
06/10/1998CN1038673C Insecticidal N' -substituted -N, N' -diacylhydrazines and its composition and use
06/09/1998US5763640 Oximinomethylphenyl derivatives
06/09/1998US5763625 Enhance lethality of dna damaging agents in neoplastic cells
06/09/1998US5763470 Benzopyran compounds and methods for their use
06/09/1998US5763414 Administering to mammal to treat hypercholesterolemia
06/09/1998US5763389 Using an alkaline aqueous extractant having a ph above the isoelectric point of the vegetable protein material; removing insolubles and contacting with a hydrolase; anticarcinogenic agents
06/09/1998CA2111223C Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
06/04/1998WO1998023565A2 Aminoguanidines and alkoxyguanidines as protease inhibitors
06/04/1998WO1998023267A1 Use of hydroxyguanidines
06/04/1998CA2272932A1 Use of hydroxyguanidines
06/03/1998EP0845216A1 A composition for administration to animals containing a tocopheryl phosphate
06/03/1998EP0844995A1 Preparation of alpha-tocopherol
06/03/1998EP0587837B1 Cosmetic composition containing melanistic pigments in association with certain tocopherols, and method for protecting the skin, the hair, the mucous membranes and cosmetic compositions
06/03/1998CN1183475A Aglucone isoflavone enriched vegetable protein extract and protein material, and high genistein and daidzein content materials and process for producing the same
06/03/1998CN1183412A New benzopyran compounds, process for preparating them and pharmaceutical compositions containing them
06/02/1998US5760250 Process for the preparation of 3-(α-methoxy)methylenebenzofuranones and intermediates therefor
06/02/1998US5760246 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
06/02/1998US5760074 Central nervous system disorders
06/02/1998US5759959 Selective control of monocotyledenous weeds in the presence of a crop plant
05/1998
05/28/1998WO1998022612A1 Novel antitumor compounds and use thereof
05/28/1998WO1998022434A1 Glyoxylic acid amides
05/28/1998DE19648009A1 Glyoxylsäureamide Glyoxylamides
05/27/1998EP0844245A1 Benzopyran derivatives, process for their preparation and pharmaceutical compositions containing them
05/27/1998EP0720551B1 Hydraulic system for anti-lock braking installations in motor vehicles
05/27/1998CN1182741A 3 -amidochromanylsulfonyl (thio) ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them
05/26/1998US5756820 Propargyl Ethers
05/26/1998US5756538 Reducing the sedative and relaxant side effect
05/26/1998US5756533 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/26/1998US5756098 Methods for the extraction of phytochemicals from fibrous plants in the absence of solvent
05/22/1998WO1998021197A2 PROCESS FOR MANUFACTURING d,l-α-TOCOPHEROL
05/20/1998EP0842928A1 Process for producing isochroman compounds
05/20/1998EP0842927A1 3-Amido-chromanylsulfonyl(thio)ureas, process for their preparation, their use and medicaments containing them
05/20/1998EP0842660A1 Composition for treating condyloma acuminata
05/20/1998CN1182075A Method of producing 2 -substituted -3, 4 -fused heterocycle benzoic acid
05/19/1998US5753695 Flavilium compounds and method of using
05/19/1998US5753674 Administering enzyme inhibitors as anticancer agents
05/19/1998US5753146 Containing atleast two photochromatic compounds, such as 3(h)-naphtho(2,1-b)pyrans and 2(h)-naphtho(1,2-b)pyrans, free of amino substituted aryl groups on carbon atom adjacent to the oxygen atom of pyran ring, exposed to ultraviolet rays
05/13/1998EP0841063A1 Ketone derivatives and medicinal use thereof
05/12/1998US5750711 Intermediates for heat resistant polymers
05/12/1998US5750693 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
05/12/1998US5750564 Anti-oxidant esters of non-steroidal anti-inflammatory agents
05/12/1998US5750544 Cardiovascular disorders; antiischemic agents; brain disorders; antiasthma agents; antiinflammatorey agents; antiulcer agents; skin disorders; antallergens
05/12/1998US5750139 Contained in inner space between impermeable top layer and microporous membrane welded togather
05/07/1998WO1998018779A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018778A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018777A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018776A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018775A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018774A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018773A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
05/07/1998WO1998018771A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018770A1 A process for the preparation of (-)-3,4-trans-diarylchromans
05/07/1998CA2270113A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270111A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270056A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270055A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes